BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 34043413)

  • 1. Hepatocellular Carcinoma in Sub-Saharan Africa.
    Kedar Mukthinuthalapati VVP; Sewram V; Ndlovu N; Kimani S; Abdelaziz AO; Chiao EY; Abou-Alfa GK
    JCO Glob Oncol; 2021 May; 7():756-766. PubMed ID: 34043413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular carcinoma risk in sub-Saharan African and Afro-Surinamese individuals with chronic hepatitis B living in Europe.
    Patmore LA; van Eekhout KMA; Buti M; Koc ÖM; Agarwal K; de Knegt RJ; Janssen HLA; van der Valk M; Lieveld FI; Hansen BE; Kramer M; de Bruijne J; Claassen MAA; Smit C; de Man RA; Takkenberg B; Carey I; Sonneveld MJ;
    J Hepatol; 2024 Feb; 80(2):243-250. PubMed ID: 37898348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma.
    Kew MC
    Pathol Biol (Paris); 2010 Aug; 58(4):273-7. PubMed ID: 20378277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of liver cirrhosis in individuals with hepatitis B virus infection in sub-Saharan Africa: Systematic review and meta-analysis.
    Surial B; Wyser D; Béguelin C; Ramírez-Mena A; Rauch A; Wandeler G
    Liver Int; 2021 Apr; 41(4):710-719. PubMed ID: 33220137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic hepatitis B virus infection and the risk of hepatocellular carcinoma by age and country of origin in people living in Sweden: A national register study.
    Duberg AS; Lybeck C; Fält A; Montgomery S; Aleman S
    Hepatol Commun; 2022 Sep; 6(9):2418-2430. PubMed ID: 35503810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The current situation and challenges of screening for and treating hepatitis B in sub-Saharan Africa.
    Béguelin C; Fall F; Seydi M; Wandeler G
    Expert Rev Gastroenterol Hepatol; 2018 Jun; 12(6):537-546. PubMed ID: 29737218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus-associated hepatocellular carcinoma in South Africa in the era of HIV.
    Maponga TG; Glashoff RH; Vermeulen H; Robertson B; Burmeister S; Bernon M; Omoshoro-Jones J; Ruff P; Neugut AI; Jacobson JS; Preiser W; Andersson MI
    BMC Gastroenterol; 2020 Jul; 20(1):226. PubMed ID: 32660431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance for hepatocellular carcinoma in people of African ancestry with HIV and Hepatitis B.
    Patel N; Post FA
    Int J STD AIDS; 2022 Feb; 33(2):202-204. PubMed ID: 34546112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of hepatocellular carcinoma.
    Yu MC; Yuan JM; Govindarajan S; Ross RK
    Can J Gastroenterol; 2000 Sep; 14(8):703-9. PubMed ID: 11185536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral therapy for chronic hepatitis B virus infection and development of hepatocellular carcinoma in a US population.
    Gordon SC; Lamerato LE; Rupp LB; Li J; Holmberg SD; Moorman AC; Spradling PR; Teshale EH; Vijayadeva V; Boscarino JA; Henkle EM; Oja-Tebbe N; Lu M;
    Clin Gastroenterol Hepatol; 2014 May; 12(5):885-93. PubMed ID: 24107395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic hepatitis B virus infection in Asian countries.
    Merican I; Guan R; Amarapuka D; Alexander MJ; Chutaputti A; Chien RN; Hasnian SS; Leung N; Lesmana L; Phiet PH; Sjalfoellah Noer HM; Sollano J; Sun HS; Xu DZ
    J Gastroenterol Hepatol; 2000 Dec; 15(12):1356-61. PubMed ID: 11197043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of development of hepatocellular carcinoma in Japanese patients infected with hepatitis B virus is equivalent between genotype B and C in long term.
    Haga H; Saito T; Okumoto K; Tomita K; Katsumi T; Mizuno K; Nishina T; Watanabe H; Ueno Y
    J Viral Hepat; 2019 Jul; 26(7):866-872. PubMed ID: 30924226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of cumulative incidence of hepatocellular carcinoma in hepatitis B virus patients without antiviral therapy.
    Jiang XY; Huang B; Huang DP; Wei CS; Zhong WC; Peng DT; Huang FR; Tong GD
    World J Gastroenterol; 2021 Mar; 27(11):1101-1116. PubMed ID: 33776376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Battlefield against hepatitis B infection and HCC in Africa.
    Lemoine M; Thursz MR
    J Hepatol; 2017 Mar; 66(3):645-654. PubMed ID: 27771453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prior surveillance and antiviral treatment improve the prognosis of HCC developed in HBV patients in the West.
    Allaire M; El Hajj W; Brichler S; Diallo K; Fanica D; Blaise L; Nkontchou G; Grando V; Arbadi F; Nahon P; Ziol M; Nault JC; Ganne-Carrié N
    Clin Res Hepatol Gastroenterol; 2021 Jan; 45(1):101436. PubMed ID: 32418851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of Liver Cancer in Africa: Current and Future Trends.
    Okeke E; Davwar PM; Roberts L; Sartorius K; Spearman W; Malu A; Duguru M
    Semin Liver Dis; 2020 May; 40(2):111-123. PubMed ID: 31726474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk stratification in chronic hepatitis B patients for hepatocellular carcinoma surveillance: management in migrant sub-Saharan African populations.
    Cargill Z; Brown SE; Dusheiko G; Agarwal K
    Gut; 2021 Mar; 70(3):629-630. PubMed ID: 32606207
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term effect of lamivudine treatment on the incidence of hepatocellular carcinoma in patients with hepatitis B virus infection.
    Kurokawa M; Hiramatsu N; Oze T; Yakushijin T; Miyazaki M; Hosui A; Miyagi T; Yoshida Y; Ishida H; Tatsumi T; Kiso S; Kanto T; Kasahara A; Iio S; Doi Y; Yamada A; Oshita M; Kaneko A; Mochizuki K; Hagiwara H; Mita E; Ito T; Inui Y; Katayama K; Yoshihara H; Imai Y; Hayashi E; Hayashi N; Takehara T
    J Gastroenterol; 2012 May; 47(5):577-85. PubMed ID: 22231575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating microRNA's as a diagnostic tool for hepatocellular carcinoma in a hyper endemic HIV setting, KwaZulu-Natal, South Africa: a case control study protocol focusing on viral etiology.
    Sartorius K; Sartorius B; Kramvis A; Singh E; Turchinovich A; Burwinkel B; Madiba T; Winkler CA
    BMC Cancer; 2017 Dec; 17(1):894. PubMed ID: 29282036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of HBV therapy on the incidence of hepatocellular carcinoma.
    Triolo M; Della Corte C; Colombo M
    Liver Int; 2014 Feb; 34 Suppl 1():139-45. PubMed ID: 24373091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.